Commonwealth of Pennsylvania

Public bodyUnited Statespa.gov

Its role Funder

project tracked
1
partner company
1
news articles
2

The Commonwealth of Pennsylvania serves as the governmental authority for the state of Pennsylvania in the United States of America. It encompasses the executive, legislative, and judicial branches responsible for enacting and enforcing state laws, managing public resources, and delivering essential services to its residents.

Read more

Primary activities include economic development, education, public health, transportation, and environmental regulation. Through its Department of Community and Economic Development, the Commonwealth promotes business growth, job creation, and investment attraction, often providing financial incentives and support for major industrial projects in sectors such as pharmaceuticals and manufacturing.

The government is headquartered in Harrisburg, the state capital, and operates under the leadership of an elected governor. It maintains various agencies and departments that coordinate with local governments and federal entities. Pennsylvania's economy benefits from its strategic location, diverse industries, and initiatives aimed at fostering innovation and sustainability.

In the context of large-scale developments, the Commonwealth plays a key role in facilitating investments by offering grants and other forms of support, contributing to the state's position as a hub for advanced manufacturing and life sciences. Its structure allows for coordinated efforts in regional economic development across the state.

Also known as PA.

The project Commonwealth of Pennsylvania is involved in

chemXplore tracks 1 project involving Commonwealth of Pennsylvania, of which one is active.

Lilly Lehigh Valley injectable medicine and device plant
  1. Announced / Concept
  2. FEED / Pre-FID
  3. FID / Sanctioned
  4. Under Construction
  5. Commissioning & Start-up
Phase
Under Construction
Where
United States
Makes
Retatrutide
Partners
Lilly

Commonwealth of Pennsylvania in chemical industry news

12 November 2026
Lilly starts construction of $3.5bn obesity-medicine plant in Pennsylvania

The Fogelsville facility will make injectable medicines, including investigational retatrutide, and is expected to be operational by 2031.

30 January 2026
Lilly to Build $3.5B Manufacturing Facility in Pennsylvania

The new facility will create 2,800 jobs, produce weight-loss medicines, and boost the local economy with advanced technologies and partnerships in education and workforce development.

Where its projects are

active all projects